Reproducibility of AJCC Criteria for Classifying Deeply Invasive Colon Cancers Is Suboptimal for Consistent Cancer Staging.
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
entrez:
15
9
2020
pubmed:
16
9
2020
medline:
28
11
2020
Statut:
ppublish
Résumé
The eighth edition of the American Joint Committee on Cancer (AJCC) Staging Manual attempts to address ambiguity in the pT category assignment for colon cancer from prior editions. Despite modifications, the distinction between the pT3 and pT4a categories continues to be a source of diagnostic confusion. In this study, we assessed interobserver agreement among pathologists from different institutions in the application of AJCC eighth edition criteria for categorizing deeply invasive colonic adenocarcinomas. We identified morphologic patterns that produce diagnostic confusion. We assessed 47 colon cancers that closely approached the serosal surface. Six pathologists with interest in gastrointestinal pathology and 4 focused in other subspecialties classified each case as pT3 or pT4a, based on examination of low-magnification and high-magnification images of the most deeply invasive area. Interobserver agreement was assessed using Fleiss' κ. Cases displayed 3 morphologic patterns at the advancing tumor edge, namely, (1) continuous invasion through an inflammatory focus, (2) pushing border, and (3) infiltrative glands and cell clusters with serosal reaction. Gastrointestinal pathologists achieved slight (κ=0.21) or moderate (κ=0.46) and (κ=0.51) agreement in each category, whereas agreement among nongastrointestinal pathologist was fair (0.31) and (0.39), or moderate (0.57) for each category, respectively. In 10 (21%) cases, the distinction between pT3 and pT4a would have changed the overall clinical stage. We conclude that histologic criteria for serosal penetration is a persistent source of diagnostic ambiguity for gastrointestinal and general pathologists in the pT categorization of colon cancers. Clarification of these criteria will help ensure uniform reporting of pathologic and clinical stage.
Identifiants
pubmed: 32931163
doi: 10.1097/PAS.0000000000001510
pii: 00000478-202010000-00009
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1381-1388Références
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
Jessup JM, Goldberg RM, Asare EA, et alAmin M. Colon and rectum. AJCC Cancer Staging Manual, 8th ed. New York, NY: Springer Nature; 2017:251–264.
College of American Pathologists. Cancer protocol templates. Colon and rectum; 2018. Available at: https://documents.cap.org/protocols/cp-gilower-colonrectum-17protocol-4010.pdf. Accessed August 15, 2019.
American College of Surgeons Commission on Cancer. CoC Standards and Resources; 2016. Available at: www.facs.org/quality-programs/cancer/coc/standards. Accessed August 15, 2019.
Edge S, Byrd D, Compton C, et alEdge S, Byrd D, Compton C, Fritz A, Greene F, Trotti AI. Colon and rectum. AJCC Cancer Staging Manual, 7th ed. New York, NY: Springer-Verlag; 2010:143–164.
Frankel WL, Jin M. Serosal surfaces, mucin pools, and deposits, oh my: challenges in staging colorectal carcinoma. Mod Pathol. 2015;28 (suppl 1):S95–S108.
Panarelli NC, Schreiner AM, Brandt SM, et al. Histologic features and cytologic techniques that aid pathologic stage assessment of colonic adenocarcinoma. Am J Surg Pathol. 2013;37:1252–1258.
Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology. 1997;112:1096–1102.
National Comprehensive Cancer Network (NCCN). National Comprehensive Cancer Network Guidelines and Clinican Resources. Colon cancer. 2016. Available at: www.nccn.org/professionals/physician_gls/default.aspx. Accessed May 5, 2019.
Snaebjornsson P, Coupe VM, Jonasson L, et al. pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd’s local peritoneal involvement revisited. Int J Cancer. 2014;135:467–478.
Smith NJ, Bees N, Barbachano Y, et al. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials. Br J Cancer. 2007;96:1030–1036.
Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012;13:1152–1160.
Merkel S, Mansmann U, Siassi M, et al. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis. 2001;16:298–304.
Greene F, Page D, Fleming IGreene F, Page D, Fleming I, Fritz AG, Balch CM, Haller DG, Morrow M. Colon and rectum. AJCC Cancer Staging Manual, 6th ed. Chicago, IL: Springer; 2002:113–125.
Gunderson LL JJ, Sargent DJ, Greene FL, et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264–271.
Karamchandani DM, Chetty R, King TS, et al. Challenges with colorectal cancer staging: results of an international study. Mod Pathol. 2020;33:153–163.
Kojima M, Nakajima K, Ishii G, et al. Peritoneal elastic laminal invasion of colorectal cancer: the diagnostic utility and clinicopathologic relationship. Am J Surg Pathol. 2010;34:1351–1360.
Kojima M, Shimazaki H, Iwaya K, et al. Practical utility and objectivity: does evaluation of peritoneal elastic laminal invasion in colorectal cancer overcome these contrary problems? Am J Surg Pathol. 2014;38:144–145.
Kojima M, Yokota M, Saito N, et al. Elastic laminal invasion in colon cancer: diagnostic utility and histological features. Front Oncol. 2012;2:179.